|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Mental Health (NIMH) |
| Information provided by: | National Institute of Mental Health (NIMH) |
| ClinicalTrials.gov Identifier: | NCT00523029 |
Purpose
This study seeks to adapt an existing chronic disease self-management program for people with both chronic medical illness and depression.
| Condition | Intervention |
|
Depression |
Behavioral: Chronic Disease Self-Management Program |
| MedlinePlus related topics: | Coping with Chronic Illness Depression |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Self-Management of Depression and Medical Illness |
| Estimated Enrollment: | 48 |
| Study Start Date: | February 2006 |
| Estimated Study Completion Date: | June 2008 |
| Estimated Primary Completion Date: | June 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|
1: Experimental
Participants will receive a chronic disease self-management program
|
Behavioral: Chronic Disease Self-Management Program
Chronic disease self-management is a 6-week group program that teaches participants how to manage their chronic medical illness. Group leaders, also suffering from a chronic medical condition, will lead discussions based on the following topics: nutrition; exercise; appropriate use of medications; ways to communicate effectively with family, friends, and health care professionals; and how to make informed treatment decisions.
|
Depression is a common but serious disorder that affects millions of people every year. Depression can severely impact people's lives, causing them to often feel sad and hopeless as well as affecting their sleep patterns, concentration, and energy levels. Treatment typically includes a combination of antidepressant medication and talk therapy. This study will evaluate the effectiveness of an adapted group education program typically used for chronic medical illness in improving the health status, health behaviors, and use of health care services among people with depression and a chronic illness.
Participants in this open-label study will attend a group education program used to manage chronic medical illness. Group sessions will be held for 2.5 hours, once a week, for 6 weeks. Group leaders, also suffering from a chronic medical condition, will lead discussions based on the following topics: nutrition; exercise; appropriate use of medications; ways to communicate effectively with family, friends, and health care professionals; and how to make informed treatment decisions. Participants will also complete two surveys: one at the beginning of the study and one at the end. The first survey will ask basic questions related to participants' health status and any feelings of stress, anxiety, or sadness. The second survey will include a brief interview that will require participants to describe their experience in the group sessions and to suggest ways of improving the program to better accommodate people with depression and chronic illness. Responses to questions will be used to enhance the effectiveness of the group education program for treating people with both depression and a chronic medical condition.
Eligibility
| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria for Patients:
Inclusion Criteria for Group Leaders:
Exclusion Criteria for Patients:
Contacts and Locations| Contact: Jennifer Green, MSW | 323-442-4044 | jennifmg@usc.edu |
| United States, California | |||||
| Edward R. Roybal Comprehensive Health Center | Active, not recruiting | ||||
| Los Angeles, California, United States, 90022 | |||||
| LAC and USC Medical Center, Outpatient Department | Recruiting | ||||
| Los Angeles, California, United States, 90033 | |||||
| Principal Investigator: | Isabel T. Lagomasino, MD, MSHS | University of Southern California |
More Information
| Responsible Party: | University of Southern California ( Isabel Lagomasino, MD, MSHS ) |
| Study ID Numbers: | R34 MH72631, DSIR 82-SEPC |
| First Received: | August 28, 2007 |
| Last Updated: | March 6, 2008 |
| ClinicalTrials.gov Identifier: | NCT00523029 |
| Health Authority: | United States: Federal Government |
|
|